Načítá se...
Montelukast: More than a Cysteinyl Leukotriene Receptor Antagonist?
The prototype cysteinyl leukotriene receptor antagonist, montelukast, is generally considered to have a niche application in the therapy of exercise- and aspirin-induced asthma. It is also used as add-on therapy in patients whose asthma is poorly controlled with inhaled corticosteroid monotherapy, o...
Uloženo v:
| Vydáno v: | ScientificWorldJournal |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
TheScientificWorldJOURNAL
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5763941/ https://ncbi.nlm.nih.gov/pubmed/21170491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/tsw.2010.229 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|